Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis
暂无分享,去创建一个
G. Gambaro | B. Baggio | A. Fracasso | G. Bazzato | Giovanni Gambaro | Bruno Baggio | Giorgio Bazzato | Agostino Fracasso
[1] G. Gambaro,et al. Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: molecular clues for its activity in nephropathy. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] G. Gambaro,et al. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. , 1994, Kidney international.
[3] D. Oreopoulos,et al. Glycosaminoglycan chondroitin sulphate prevents loss of ultrafiltration during peritoneal dialysis in rats. , 1994, Nephron.
[4] G. Gambaro,et al. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. , 1992, Kidney international.
[5] E. Nilsson,et al. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. , 1991, The Journal of clinical investigation.
[6] E. Ruoslahti. Proteoglycans in cell regulation. , 1989, Journal of Biological Chemistry.
[7] A. Coffey,et al. Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury. , 1985, The American journal of pathology.
[8] A. Clowes,et al. Suppression by heparin of smooth muscle cell proliferation in injured arteries , 1977, Nature.